HIV / AIDS
CROI 2013: Researchers Look at Neurological Complications among People with HIV
- Details
- Category: HIV-Related Conditions
- Published on Monday, 25 March 2013 00:00
Data from a small, yet well-designed trial to evaluate whether particular antiretroviral therapy (ART) regimens penetrate the central nervous system (CNS) and enhance neurocognitive performance were among several interesting findings regarding neurological complications among people with HIV presented at the 20th Conference on Retroviruses and Opportunistic Infections (CROI 2013) this month in Atlanta. Another study looked at similarities between Alzheimer's disease and neurocognitive impairment in people with HIV.
CROI 2013: Transmitted Antiretroviral Drug Resistance Holds Steady at 16% [VIDEO]
- Details
- Category: HIV Treatment
- Published on Monday, 25 March 2013 00:00
Approximately 1 in 6 analyzed HIV sequences showed evidence of antiretroviral drug resistance, with NNRTIs being particularly vulnerable, according to a CDC analysis presented at the recent 20th Conference on Retroviruses and Opportunistic Infections (CROI 2013) in Atlanta.
CROI 2013: Statins for People with HIV -- How Sweet Is It?
- Details
- Category: HIV-Related Conditions
- Published on Thursday, 21 March 2013 00:00
Statins may help reduce co-morbid conditions such as cardiovascular disease and lower mortality for some people with HIV, but with a possible trade-off of higher diabetes risk, according to a series of studies presented and discussed at 20th Conference on Retroviruses and Opportunistic Infections (CROI 2013) this month in Atlanta.
CROI 2013: Women's PrEP Trial Does Not Show HIV Risk Reduction [VIDEO]
- Details
- Category: HIV Prevention
- Published on Sunday, 24 March 2013 00:00
Long-awaited results from the VOICE trial of post-exposure prophylaxis (PrEP) for women in Africa, presented at the recent 20th Conference on Retroviruses and Opportunistic Infections (CROI 2013) in Atlanta, was not able to show that daily oral tenofovir plus emtricitabine (the drugs in Truvada) could lower the risk of HIV acquisition.
CROI 2013: Functional Cure of HIV-infected Infant after Early ART [VIDEO]
- Details
- Category: Search for a Cure
- Published on Wednesday, 20 March 2013 00:00
The big news on the opening day of the 20th Conference on Retroviruses and Opportunistic Infections (CROI 2013) was a report about an infant with HIV who started combination antiretroviral treatment very early and now shows no evidence of replication-competent virus. "We equate this to our Berlin Patient," said Deborah Persaud from Johns Hopkins University School of Medicine. "It could get us on the road to a cure for HIV-infected children."
CROI 2013: Maraviroc Does Not Prevent Immune Reconstitution Syndrome [VIDEO]
- Details
- Category: HIV Prevention
- Published on Sunday, 24 March 2013 00:00
The CCR5 co-receptor blocker maraviroc (Selzentry) did not reduce the risk of developing immune reconstitution inflammatory syndrome (IRIS) after starting antiretroviral therapy (ART), according to study findings presented at the recent 20th Conference on Retroviruses and Opportunistic Infections (CROI 2013) in Atlanta.
CROI 2013: HIV and Aging -- Are People with HIV at Greater Risk for Heart Disease and Cancer? [VIDEO]
- Details
- Category: HIV-Related Conditions
- Published on Wednesday, 20 March 2013 00:00
Keri Althoff from the VA Medical Center and George Washington University Medical School described findings from a study looking at risk of non-AIDS conditions such as cardiovascular disease and cancer at the 20th Conference on Retroviruses and Opportunistic Infections (CROI 2013) this month in Atlanta.
More Articles...
- New Advocacy Group Wants to Improve Feasibility of PrEP for U.S. Women
- CROI 2013: Second-line NRTI-sparing HIV Regimen Proves Equally Effective
- CROI 2013: Small Risk of Birth Defects Due to Efavirenz Confirmed in French Cohort
- CROI 2013: HIV+ Men at Increased Risk for Co-morbid Conditions Regardless of Age
- CROI 2013: Heart Disease Rises Only Slighter Faster with Age for People with HIV
Web Design and Development by